Invention Grant
- Patent Title: Immunogenic composition
-
Application No.: US15691440Application Date: 2017-08-30
-
Publication No.: US10166287B2Publication Date: 2019-01-01
- Inventor: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
- Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee Address: BE Rixensart
- Agency: Seed IP Law Group LLP
- Priority: GB0513069.5 20050627; GB0513071.1 20050627; GB0515556.9 20050728; GB0524204.5 20051128; GB0526040.1 20051221; GB0526041.9 20051221
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/385 ; A61K39/095 ; A61K39/102 ; A61K39/116 ; C07H3/00 ; A61K39/05 ; A61K39/08 ; A61K39/09 ; A61K39/02 ; A61K39/29 ; A61K39/145 ; C12N7/00 ; A61K39/12
Abstract:
present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.
Public/Granted literature
- US20180064806A1 IMMUNOGENIC COMPOSITION Public/Granted day:2018-03-08
Information query
